Ledger.Open graph →
SEC Form D · filed April 17, 2014

PROVECTUS BIOPHARMACEUTICALS, INC

Offering
$5.0M
Sold
$3.4M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
KNOXVILLE, TN
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (13)

Philippe Boisseau · EMERYVILLE, CAExec · DirectorTimothy C. Scott · Knoxville, TNExec · DirectorRaffi Asadorian · EMERYVILLE, CADirectorNancy K. Naeve · IRVINE, CADirectorInderjit Singh · Grand Cayman, Cayman IslandsExecBrian A. Dahn · IRVINE, CAExecElizabeth T. Gile · New York, NYExecDahn America360, LLC · IRVINE, CAExecFernando J. Reinach · EMERYVILLE, CADirectorJoel Cherry · EMERYVILLE, CADirectorGeoffrey J. Duyk · EMERYVILLE, CADirectorRaleigh A. Shoemaker · BOSTON, MAExec · DirectorDavid W. Menard · Wayne, PAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗